PEAK RSI Chart
Last 7 days
3.1%
Last 30 days
3.0%
Last 90 days
7.4%
Trailing 12 Months
-37.2%
Historical Charts for Stock Metrics
Year | Q1 | Q2 | Q3 | Q4 |
---|---|---|---|---|
2024 | 2.3B | 0 | 0 | 0 |
2023 | 2.1B | 2.1B | 2.2B | 2.2B |
2022 | 1.9B | 2.0B | 2.0B | 2.1B |
2021 | 1.7B | 1.8B | 1.8B | 1.9B |
2020 | 1.3B | 1.4B | 1.5B | 1.6B |
2019 | 1.7B | 1.5B | 1.4B | 1.2B |
2018 | 1.8B | 1.8B | 1.8B | 1.8B |
2017 | 2.1B | 2.0B | 1.9B | 1.8B |
2016 | 2.0B | 2.1B | 2.1B | 2.1B |
2015 | 2.2B | 2.1B | 2.0B | 1.9B |
2014 | 2.1B | 2.1B | 2.2B | 2.3B |
2013 | 1.9B | 2.0B | 2.1B | 2.1B |
2012 | 1.8B | 1.8B | 1.8B | 1.9B |
2011 | 1.3B | 1.5B | 1.6B | 1.7B |
2010 | 1.2B | 1.2B | 1.2B | 1.3B |
2009 | 1.2B | 1.2B | 1.2B | 1.1B |
2008 | 0 | 1.0B | 1.1B | 1.1B |
2007 | 0 | 0 | 0 | 945.8M |
Datesorted ascending | Name | Buy/Sell | $ Value | Avg. Price | # Shares | Title |
---|---|---|---|---|---|---|
Feb 15, 2024 | alonso lisa a | sold (taxes) | -9,020 | 16.86 | -535 | evp and chief hr officer |
Feb 12, 2024 | bohn scott r | sold (taxes) | -45,656 | 17.34 | -2,633 | cdo and head of lab |
Feb 12, 2024 | brinker scott m | sold (taxes) | -86,353 | 17.34 | -4,980 | president and ceo |
Feb 12, 2024 | alonso lisa a | sold (taxes) | -7,508 | 17.34 | -433 | evp and chief hr officer |
Feb 10, 2024 | brinker scott m | sold (taxes) | -97,554 | 17.34 | -5,626 | president and ceo |
Feb 10, 2024 | alonso lisa a | sold (taxes) | -7,629 | 17.34 | -440 | evp and chief hr officer |
Feb 02, 2024 | alonso lisa a | sold (taxes) | -4,272 | 18.82 | -227 | evp and chief hr officer |
Feb 01, 2024 | alonso lisa a | acquired | - | - | 3,328 | evp and chief hr officer |
Oct 03, 2023 | alonso lisa a | sold (taxes) | -18,166 | 17.81 | -1,020 | evp and chief hr officer |
Apr 28, 2023 | garvey christine | acquired | - | - | 8,193 | - |
Which funds bought or sold PEAK recently?
View All DetailsDatesorted ascending | Fund Name | Type | % Chg | $ Change | $ Held | % Portfolio |
---|---|---|---|---|---|---|
May 06, 2024 | Investors Research Corp | unchanged | - | -302 | 5,381 | -% |
May 06, 2024 | Addison Advisors LLC | reduced | -92.18 | -57,460 | 4,594 | -% |
May 06, 2024 | Parallel Advisors, LLC | added | 11.2 | 10,999 | 218,444 | 0.01% |
May 06, 2024 | Diligent Investors, LLC | unchanged | - | -26,477 | 472,800 | 0.12% |
May 06, 2024 | Metis Global Partners, LLC | added | 17.00 | 249,097 | 2,557,520 | 0.09% |
May 06, 2024 | Mesirow Institutional Investment Management, Inc. | sold off | -100 | -2,697,650 | - | -% |
May 06, 2024 | Advisory Services Network, LLC | reduced | -66.58 | -1,239,620 | 573,882 | 0.01% |
May 06, 2024 | SG Americas Securities, LLC | added | 51.9 | 2,338,000 | 7,669,000 | 0.04% |
May 06, 2024 | Candriam S.C.A. | added | 7.04 | 20,863 | 1,558,120 | 0.01% |
May 06, 2024 | Hilltop National Bank | new | - | 24,375 | 24,375 | 0.01% |
Unveiling Healthpeak Properties Inc's Major ShareHolders
Date Filed | Name of Filer | Percent of Class | No. of Shares | Form Type | |
---|---|---|---|---|---|
Peers (Alternatives to Healthpeak Properties Inc)
Name | Mkt Capsorted ascending | Revenue | Price %, 1M | Returns, 1Y | P/E | P/S | Rev 1-Yr | Inc 1-Yr |
---|---|---|---|---|---|---|---|---|
LARGE-CAP | ||||||||
AMT | 84.7B | 11.2B | 42.91 | 7.56 | ||||
CCI | 41.8B | 6.8B | 29.96 | 6.1 | ||||
AVB | 27.9B | 2.8B | 29.16 | 9.93 | ||||
ARE | 20.9B | 3.0B | 106.61 | 7.09 | ||||
AMH | 13.4B | - | 31.65 | 8.24 | ||||
REG | 11.0B | 1.4B | 29.39 | 8.02 | ||||
BXP | 9.6B | 3.3B | 50.23 | 2.92 | ||||
MID-CAP | ||||||||
FRT | 8.5B | 1.2B | 35.86 | 7.43 | ||||
SLG | 3.3B | 892.3M | -6.5 | 3.73 | ||||
MAC | 3.3B | 884.1M | -12 | 3.72 | ||||
SMALL-CAP | ||||||||
AAT | 1.3B | 444.1M | 19.54 | 3.02 | ||||
AIV | 1.2B | 198.2M | -7.62 | 5.71 | ||||
MFA | 1.1B | 650.2M | 35.5 | 1.67 | ||||
NYMT | 562.0M | 285.4M | -4.08 | 1.97 | ||||
IVR | 442.4M | 277.9M | -27.9 | 1.59 |
Healthpeak Properties Inc News
Income Statement (Quarterly) | ||||||||||||||||||||||
Description | (%) Q/Q | 2024Q1 | 2023Q4 | 2023Q3 | 2023Q2 | 2023Q1 | 2022Q4 | 2022Q3 | 2022Q2 | 2022Q1 | 2021Q4 | 2021Q3 | 2021Q2 | 2021Q1 | 2020Q4 | 2020Q3 | 2020Q2 | 2020Q1 | 2019Q4 | 2019Q3 | 2019Q2 | 2019Q1 |
Revenue | 9.6% | 607 | 554 | 556 | 545 | 526 | 524 | 520 | 518 | 498 | 483 | 481 | 476 | 455 | 432 | 424 | 409 | 381 | 319 | 321 | 307 | 293 |
Costs and Expenses | 34.2% | 666 | 496 | 490 | 498 | 475 | 513 | 466 | 463 | 447 | 459 | 439 | 426 | 415 | 439 | 401 | 403 | 466 | -291 | 544 | 533 | 385 |
Operating Expenses | - | 244 | - | - | - | 223 | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
S&GA Expenses | 8.1% | 23.00 | 22.00 | 23.00 | 26.00 | 25.00 | 58.00 | 25.00 | 25.00 | 24.00 | 26.00 | 23.00 | 24.00 | 25.00 | 26.00 | 22.00 | 24.00 | 22.00 | 22.00 | 23.00 | 27.00 | 21.00 |
EBITDA Margin | -8.0% | 0.53* | 0.58* | 0.56* | 0.70* | 0.70* | 0.67* | 0.69* | 0.55* | 0.61* | 0.51* | 0.50* | 0.49* | - | - | - | - | - | - | - | - | - |
Interest Expenses | 15.4% | 61.00 | 53.00 | 51.00 | 49.00 | 48.00 | 49.00 | 44.00 | 42.00 | 38.00 | 37.00 | 36.00 | 39.00 | 47.00 | 54.00 | 54.00 | 55.00 | 56.00 | 50.00 | 61.00 | 57.00 | 49.00 |
Income Taxes | 215.7% | 14.00 | -11.84 | 1.00 | 1.00 | 0.00 | -0.65 | -3.83 | -0.72 | 1.00 | -1.86 | -0.65 | -0.76 | 0.00 | -2.63 | 23.00 | 0.00 | -29.87 | 6.00 | -6.26 | -1.86 | -3.46 |
Earnings Before Taxes | -62.5% | 22.00 | 60.00 | 67.00 | 55.00 | 133 | 9.00 | 356 | 68.00 | 74.00 | 26.00 | 58.00 | 166 | -121 | -2.87 | 14.00 | 78.00 | 128 | 149 | -19.06 | 26.00 | 20.00 |
EBT Margin | -37.4% | 0.09* | 0.14* | 0.12* | 0.26* | 0.27* | 0.25* | 0.26* | 0.11* | 0.17* | 0.07* | 0.05* | 0.03* | - | - | - | - | - | - | - | - | - |
Net Income | -90.6% | 7.00 | 71.00 | 64.00 | 52.00 | 119 | 7.00 | 354 | 68.00 | 72.00 | 29.00 | 55.00 | 276 | 146 | 146 | -63.42 | 52.00 | 279 | 44.00 | -45.86 | -13.60 | 61.00 |
Net Income Margin | -39.0% | 0.09* | 0.14* | 0.11* | 0.25* | 0.26* | 0.24* | 0.26* | 0.11* | 0.22* | 0.27* | 0.34* | 0.28* | - | - | - | - | - | - | - | - | - |
Free Cashflow | -34.0% | 153 | 231 | 253 | 298 | 174 | 207 | 244 | 255 | 194 | 224 | 212 | 237 | - | - | - | - | - | - | - | - | - |
Balance Sheet | ||||||||||||||||||||||
Description | (%) Q/Q | 2024Q1 | 2023Q4 | 2023Q3 | 2023Q2 | 2023Q1 | 2022Q4 | 2022Q3 | 2022Q2 | 2022Q1 | 2021Q4 | 2021Q3 | 2021Q2 | 2021Q1 | 2020Q4 | 2020Q3 | 2020Q2 | 2020Q1 | 2019Q4 | 2019Q3 | 2019Q2 | 2019Q1 |
Assets | 30.9% | 20,542 | 15,699 | 15,603 | 15,604 | 15,602 | 15,771 | 15,662 | 15,318 | 15,287 | 15,258 | 14,744 | 14,332 | 15,194 | 15,920 | 15,752 | 16,316 | 16,073 | 14,033 | 14,010 | 13,713 | 12,900 |
Cash Equivalents | -13.5% | 102 | 118 | 63.00 | 104 | 59.00 | 72.00 | 112 | 73.00 | 89.00 | 158 | 201 | 97.00 | 34.00 | 44.00 | 140 | 672 | 717 | 80.00 | 125 | 131 | 120 |
Liabilities | 24.7% | 10,943 | 8,774 | 8,570 | 8,478 | 8,379 | 8,483 | 8,536 | 8,362 | 8,242 | 8,111 | 7,405 | 6,899 | 7,877 | 8,573 | 8,346 | 8,648 | 8,259 | 7,365 | 7,487 | 7,094 | 6,500 |
Shareholder's Equity | 39.9% | 8,882 | 6,350 | 6,457 | 7,062 | 7,138 | 7,183 | 6,999 | 6,840 | 6,948 | 7,059 | 7,219 | 7,351 | 7,241 | 7,290 | 7,362 | 7,637 | 7,813 | 6,659 | 6,523 | 6,619 | 6,399 |
Additional Paid-In Capital | 24.2% | 12,919 | 10,406 | 10,402 | 10,385 | 10,360 | 10,350 | 10,015 | 10,074 | 10,085 | 10,100 | 10,122 | 10,230 | 10,224 | 10,175 | 10,228 | 10,223 | 10,213 | 9,184 | 8,905 | 8,801 | 8,405 |
Shares Outstanding | 28.6% | 704 | 547 | 547 | 547 | 547 | 547 | 538 | 539 | 539 | 539 | 539 | 539 | - | - | - | - | - | - | - | - | - |
Minority Interest | 26.1% | 663 | 526 | 527 | 527 | 528 | 528 | 532 | 535 | 539 | 543 | 548 | 549 | 552 | 556 | 566 | 570 | 577 | 582 | 590 | 565 | 562 |
Float | - | - | - | - | 9,200 | - | - | - | 10,200 | - | - | - | 12,800 | - | - | - | 12,500 | - | - | - | 13,200 | - |
Cashflow (Quarterly) | ||||||||||||||||||||||
Description | (%) Q/Q | 2024Q1 | 2023Q4 | 2023Q3 | 2023Q2 | 2023Q1 | 2022Q4 | 2022Q3 | 2022Q2 | 2022Q1 | 2021Q4 | 2021Q3 | 2021Q2 | 2021Q1 | 2020Q4 | 2020Q3 | 2020Q2 | 2020Q1 | 2019Q4 | 2019Q3 | 2019Q2 | 2019Q1 |
Cashflow From Operations | -34.0% | 152,564 | 231,248 | 253,257 | 297,816 | 173,921 | 206,955 | 243,638 | 255,485 | 194,183 | 223,913 | 211,741 | 236,868 | 122,726 | 218,707 | 219,901 | 224,781 | 95,042 | 217,472 | 248,041 | 221,978 | 158,582 |
Share Based Compensation | -4.2% | 3,366 | 3,514 | 3,434 | 4,245 | 3,287 | 11,821 | 4,614 | 5,300 | 4,721 | 4,307 | 4,436 | 5,095 | 4,364 | 3,976 | 4,420 | 4,140 | 4,832 | 3,633 | 4,171 | 6,247 | 4,111 |
Cashflow From Investing | 54.7% | -97,781 | -215,668 | -222,417 | -195,014 | 56,345 | -298,230 | -116,977 | -215,174 | -245,962 | -672,643 | -508,621 | 944,570 | 767,726 | -241,222 | -231,208 | -384,259 | -151,011 | -7,264 | -352,537 | -928,700 | -160,277 |
Cashflow From Financing | -268.7% | -66,648 | 39,516 | -77,438 | -59,502 | -239,875 | 48,985 | -93,435 | -53,571 | -18,511 | 399,372 | 321,383 | -1,085,153 | -924,119 | -95,338 | -525,796 | 106,163 | 761,421 | -180,977 | 103,590 | 716,137 | 8,521 |
Dividend Payments | 0.1% | 164,200 | 164,084 | 164,007 | 163,954 | 164,976 | 161,087 | 161,684 | 161,829 | 163,447 | 161,998 | 161,995 | 161,971 | 164,118 | 199,476 | 199,546 | 199,550 | 188,500 | 183,463 | 182,110 | 177,264 | 177,286 |
Buy Backs | 283219.4% | 101,995 | 36.00 | 14.00 | 7.00 | 6,467 | 196 | 56,028 | 263 | 11,352 | 288 | 73.00 | 315 | 12,165 | 256 | 275 | 261 | 9,737 | 112 | 349 | 1,663 | 2,919 |
CONSOLIDATED STATEMENTS OF OPERATIONS - USD ($) shares in Thousands, $ in Thousands | 3 Months Ended | |
---|---|---|
Mar. 31, 2024 | Mar. 31, 2023 | |
Revenues [Abstract] | ||
Rental and related revenues | $ 462,033 | $ 392,431 |
Resident fees and services | 138,776 | 127,084 |
Interest income and other | 5,751 | 6,163 |
Total revenues | 606,560 | 525,678 |
Costs and expenses: | ||
Interest expense | 60,907 | 47,963 |
Depreciation and amortization | 219,219 | 179,225 |
Operating | 243,729 | 223,088 |
General and administrative | 23,299 | 24,547 |
Transaction and merger-related costs | 107,220 | 2,425 |
Impairments and loan loss reserves (recoveries), net | 11,458 | (2,213) |
Total costs and expenses | 665,832 | 475,035 |
Other income (expense): | ||
Gain (loss) on sales of real estate, net | 3,255 | 81,578 |
Other income (expense), net | 78,516 | 772 |
Total other income (expense), net | 81,771 | 82,350 |
Income (loss) before income taxes and equity income (loss) from unconsolidated joint ventures | 22,499 | 132,993 |
Income tax benefit (expense) | (13,698) | (302) |
Equity income (loss) from unconsolidated joint ventures | 2,376 | 1,816 |
Net income (loss) | 11,177 | 134,507 |
Noncontrolling interests’ share in earnings | (4,501) | (15,555) |
Net income (loss) attributable to Healthpeak Properties, Inc. | 6,676 | 118,952 |
Participating securities’ share in earnings | (199) | (1,254) |
Net income (loss) applicable to common shares | $ 6,477 | $ 117,698 |
Earnings (loss) per common share: | ||
Basic (in dollars per share) | $ 0.01 | $ 0.22 |
Diluted (in dollars per share) | $ 0.01 | $ 0.22 |
Weighted average shares outstanding: | ||
Basic (in shares) | 600,898 | 546,842 |
Diluted (in shares) | 601,188 | 547,110 |
CONSOLIDATED BALANCE SHEETS - USD ($) $ in Thousands | Mar. 31, 2024 | Dec. 31, 2023 |
---|---|---|
Real estate: | ||
Buildings and improvements | $ 16,571,761 | $ 13,329,464 |
Development costs and construction in progress | 735,176 | 643,217 |
Land and improvements | 3,079,225 | 2,647,633 |
Accumulated depreciation and amortization | (3,723,173) | (3,591,951) |
Net real estate | 16,662,989 | 13,028,363 |
Loans receivable, net of reserves of $9,334 and $2,830 | 267,798 | 218,450 |
Investments in and advances to unconsolidated joint ventures | 930,559 | 782,853 |
Accounts receivable, net of allowance of $2,800 and $2,282 | 68,567 | 55,820 |
Cash and cash equivalents | 101,763 | 117,635 |
Restricted cash | 55,395 | 51,388 |
Intangible assets, net | 1,160,446 | 314,156 |
Assets held for sale, net | 0 | 117,986 |
Right-of-use asset, net | 434,010 | 240,155 |
Other assets, net | 860,513 | 772,044 |
Total assets | 20,542,040 | 15,698,850 |
LIABILITIES AND EQUITY | ||
Bank line of credit and commercial paper | 183,000 | 720,000 |
Term loans | 1,645,180 | 496,824 |
Senior unsecured notes | 6,545,209 | 5,403,378 |
Mortgage debt | 382,406 | 256,097 |
Intangible liabilities, net | 238,760 | 127,380 |
Liabilities related to assets held for sale, net | 0 | 729 |
Lease liability | 307,119 | 206,743 |
Accounts payable, accrued liabilities, and other liabilities | 717,191 | 657,196 |
Deferred revenue | 923,676 | 905,633 |
Total liabilities | 10,942,541 | 8,773,980 |
Commitments and contingencies (Note 11) | ||
Redeemable noncontrolling interests | 54,848 | 48,828 |
Common stock, $1.00 par value: 1,500,000,000 and 750,000,000 shares authorized; 703,733,446 and 547,156,311 shares issued and outstanding | 703,733 | 547,156 |
Additional paid-in capital | 12,918,936 | 10,405,780 |
Cumulative dividends in excess of earnings | (4,779,599) | (4,621,861) |
Accumulated other comprehensive income (loss) | 38,543 | 19,371 |
Total stockholders’ equity | 8,881,613 | 6,350,446 |
Joint venture partners | 328,430 | 310,998 |
Non-managing member unitholders | 334,608 | 214,598 |
Total noncontrolling interests | 663,038 | 525,596 |
Total equity | 9,544,651 | 6,876,042 |
Total liabilities and equity | $ 20,542,040 | $ 15,698,850 |